Treating db/db mice with GSK-3β small molecule inhibitors Eliminates changes in TTP and HuR in the glomeruli and mitigates overexpression of their target genes, which in turn also alleviates proteinuria and DKD pathology (Guo et al., 2020). The gene discussed is ELAVL1; the disease is diabetic kidney disease.